These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1308 related items for PubMed ID: 25872541

  • 1. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN.
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [Abstract] [Full Text] [Related]

  • 2. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D, Madsbad S, Holst JJ.
    Am J Physiol Endocrinol Metab; 2012 Jul 01; 303(1):E122-31. PubMed ID: 22535748
    [Abstract] [Full Text] [Related]

  • 3. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
    Dirksen C, Bojsen-Møller KN, Jørgensen NB, Jacobsen SH, Kristiansen VB, Naver LS, Hansen DL, Worm D, Holst JJ, Madsbad S.
    Diabetologia; 2013 Dec 01; 56(12):2679-87. PubMed ID: 24048673
    [Abstract] [Full Text] [Related]

  • 4. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R, Anselmino M, Ferrannini E.
    J Clin Endocrinol Metab; 2013 Nov 01; 98(11):4391-9. PubMed ID: 24057293
    [Abstract] [Full Text] [Related]

  • 5. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS, Bojsen-Møller KN, Nielsen S, Jørgensen NB, Dirksen C, Bendtsen F, Kristiansen VB, Hartmann B, Holst JJ, Madsbad S.
    Am J Physiol Endocrinol Metab; 2016 Apr 01; 310(7):E505-14. PubMed ID: 26786780
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN, Dirksen C, Jørgensen NB, Jacobsen SH, Serup AK, Albers PH, Hansen DL, Worm D, Naver L, Kristiansen VB, Wojtaszewski JF, Kiens B, Holst JJ, Richter EA, Madsbad S.
    Diabetes; 2014 May 01; 63(5):1725-37. PubMed ID: 24241533
    [Abstract] [Full Text] [Related]

  • 8. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S.
    Obes Surg; 2012 Jul 01; 22(7):1084-96. PubMed ID: 22359255
    [Abstract] [Full Text] [Related]

  • 9. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM, Mari A, Zhao TJ, Mitchell L, Burgess S, Li X, Adams-Huet B, Lingvay I.
    Diabetes Obes Metab; 2018 Jul 01; 20(7):1710-1721. PubMed ID: 29532631
    [Abstract] [Full Text] [Related]

  • 10. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
    Promintzer-Schifferl M, Prager G, Anderwald C, Mandl M, Esterbauer H, Shakeri-Leidenmühler S, Pacini G, Stadler M, Bischof MG, Ludvik B, Luger A, Krebs M.
    Obesity (Silver Spring); 2011 Jul 01; 19(7):1420-6. PubMed ID: 21494227
    [Abstract] [Full Text] [Related]

  • 11. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
    Jirapinyo P, Jin DX, Qazi T, Mishra N, Thompson CC.
    Obes Surg; 2018 Mar 01; 28(3):615-626. PubMed ID: 28871519
    [Abstract] [Full Text] [Related]

  • 12. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
    Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G.
    Ann Surg; 2013 Mar 01; 257(3):462-8. PubMed ID: 23388352
    [Abstract] [Full Text] [Related]

  • 13. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR.
    Int J Obes (Lond); 2010 Mar 01; 34(3):462-71. PubMed ID: 20029383
    [Abstract] [Full Text] [Related]

  • 14. Updates in weight loss surgery and gastrointestinal peptides.
    Svane MS, Bojsen-Møller KN, Madsbad S, Holst JJ.
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb 01; 22(1):21-8. PubMed ID: 25517025
    [Abstract] [Full Text] [Related]

  • 15. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS, Jørgensen NB, Bojsen-Møller KN, Dirksen C, Nielsen S, Kristiansen VB, Toräng S, Wewer Albrechtsen NJ, Rehfeld JF, Hartmann B, Madsbad S, Holst JJ.
    Int J Obes (Lond); 2016 Nov 01; 40(11):1699-1706. PubMed ID: 27434221
    [Abstract] [Full Text] [Related]

  • 16. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
    Qiu NC, Zhang Q, Song X, Liu ME, Li XK, Shan CX, Qiu M.
    J Surg Res; 2014 Sep 01; 191(1):123-9. PubMed ID: 24768143
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.
    Vidal J, Nicolau J, Romero F, Casamitjana R, Momblan D, Conget I, Morínigo R, Lacy AM.
    J Clin Endocrinol Metab; 2009 Mar 01; 94(3):884-91. PubMed ID: 19106269
    [Abstract] [Full Text] [Related]

  • 18. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D, Rives-Lange C, Frigout Y, Bergerot D, Blanchard A, Le Gall M, Lacorte JM, Chevallier JM, Czernichow S, Poghosyan T, Carette C, Le Beyec J.
    Obes Surg; 2022 Mar 01; 32(3):757-762. PubMed ID: 34993850
    [Abstract] [Full Text] [Related]

  • 19. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
    Seyfried F, Miras AD, Rotzinger L, Nordbeck A, Corteville C, Li JV, Schlegel N, Hankir M, Fenske W, Otto C, Jurowich C.
    Obes Surg; 2016 Jun 01; 26(6):1228-36. PubMed ID: 26377340
    [Abstract] [Full Text] [Related]

  • 20. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
    Lips MA, de Groot GH, van Klinken JB, Aarts E, Berends FJ, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Willems van Dijk K, Pijl H.
    Clin Endocrinol (Oxf); 2014 Jun 01; 80(6):834-42. PubMed ID: 23711328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.